The airway epithelial barrier (AEB) is a critical transducer that maintains respiratory homeostasis. This review proposes a novel dual-domain respiratory exposome framework that conceptualizes how the external exposome (cumulative inhaled exposures) and the internal exposome (endogenous immune, metabolic, and endocrine networks) converge to modulate epithelial resilience dynamically. Excessive cumulative pressure disrupts this homeostatic balance, compromising junctional integrity, triggering oxidative stress, and provoking inflammation. These perturbations contribute to maladaptive airway remodeling in chronic respiratory diseases (CRDs), such as asthma and chronic obstructive pulmonary disease (COPD). Furthermore, emerging biologics that target epithelial alarmins and barrier-disruptive mediators are summarized. Finally, a next-generation precision medicine paradigm that leverages computational modeling to integrate individual expotypes (external exposure profiles) with endotypes (internal molecular signatures) is outlined. This framework offers a unified strategy for restoring AEB function and optimizing CRD management.
The airway epithelial barrier (AEB) is a critical transducer that maintains respiratory homeostasis. This review proposes a novel dual-domain respiratory exposome framework that conceptualizes how the external exposome (cumulative inhaled exposures) and the internal exposome (endogenous immune, metabolic, and endocrine networks) converge to modulate epithelial resilience dynamically. Excessive cumulative pressure disrupts this homeostatic balance, compromising junctional integrity, triggering oxidative stress, and provoking inflammation. These perturbations contribute to maladaptive airway remodeling in chronic respiratory diseases (CRDs), such as asthma and chronic obstructive pulmonary disease (COPD). Furthermore, emerging biologics that target epithelial alarmins and barrier-disruptive mediators are summarized. Finally, a next-generation precision medicine paradigm that leverages computational modeling to integrate individual expotypes (external exposure profiles) with endotypes (internal molecular signatures) is outlined. This framework offers a unified strategy for restoring AEB function and optimizing CRD management.